Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details)

v3.23.2
Note 15 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details) - $ / shares
5 Months Ended 17 Months Ended
Jun. 30, 2022
Jun. 30, 2023
Weighted average exercise price - ($/share) (in dollars per share) $ 6.41 $ 4.19
Expected life in years (Year) 6 years 6 years 4 months 24 days
Average expected volatility 72.00% 68.00%
Risk-free interest rate 1.98% 3.73%
Expected dividend yield 2.30% 5.97%
Weighted average grant date fair value - ($/share) (in dollars per share) $ 2.84 $ 2.29